Patents by Inventor Thomas Stumpfig

Thomas Stumpfig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL PHARMACEUTICAL FORMULATION FOR C-MET INHIBITOR
    Publication number: 20230338294
    Abstract: The present disclosure provides a pharmaceutical oral dosage form. In one embodiment, the dosage form comprises a formulation comprising an active pharmaceutical ingredient (API) and a polymer, wherein said API is a compound inhibiting c-Met tyrosine kinase.
    Type: Application
    Filed: April 24, 2021
    Publication date: October 26, 2023
    Inventors: Sanjeev REDKAR, Thomas STUMPFIG, Anne MUSKE-DUKES-DRIGGS, Thomas REYNOLDS, Thurman Russell FALK, Mike Tso-Ping LI, Prema VIJAYAKUMAR
  • THERAPEUTIC FORMULATIONS AND USES THEREOF
    Publication number: 20230147869
    Abstract: This invention relates to formulations of compound (I) (BNC210), an allosteric modulator of the ?7-nicotinic receptor with non-sedative anxiolytic effects; specifically, solid dispersions, methods of manufacture thereof, and therapeutic methods and uses in the treatment of diseases of the central nervous system thereof.
    Type: Application
    Filed: February 17, 2020
    Publication date: May 11, 2023
    Inventors: Dharam Paul, Julia Crossman, Elizabeth Doolin, Tom Reynolds, Xiangming Wu, Jeff Millan, Thomas Stumpfig, Kristie Downing